As of 2025-12-18, the EV/EBITDA ratio of Bolt Biotherapeutics Inc (BOLT) is 0.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. BOLT's latest enterprise value is -7.29 mil USD. BOLT's TTM EBITDA according to its financial statements is -43.08 mil USD. Dividing these 2 quantities gives us the above BOLT EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 13.4x - 15.2x | 15.0x |
| Forward P/E multiples | 18.0x - 41.1x | 21.8x |
| Fair Price | (393.74) - (332.71) | (403.61) |
| Upside | -7324.6% - -6204.8% | -7505.7% |
| Date | EV/EBITDA |
| 2025-12-17 | 0.17 |
| 2025-12-16 | 0.17 |
| 2025-12-15 | 0.17 |
| 2025-12-12 | 0.17 |
| 2025-12-11 | 0.15 |
| 2025-12-10 | 0.15 |
| 2025-12-09 | 0.15 |
| 2025-12-08 | 0.17 |
| 2025-12-05 | 0.17 |
| 2025-12-04 | 0.18 |
| 2025-12-03 | 0.18 |
| 2025-12-02 | 0.19 |
| 2025-12-01 | 0.19 |
| 2025-11-28 | 0.19 |
| 2025-11-26 | 0.19 |
| 2025-11-25 | 0.19 |
| 2025-11-24 | 0.19 |
| 2025-11-21 | 0.20 |
| 2025-11-20 | 0.20 |
| 2025-11-19 | 0.20 |
| 2025-11-18 | 0.21 |
| 2025-11-17 | 0.21 |
| 2025-11-14 | 0.21 |
| 2025-11-13 | 0.20 |
| 2025-11-12 | 0.20 |
| 2025-11-11 | 0.20 |
| 2025-11-10 | 0.19 |
| 2025-11-07 | 0.21 |
| 2025-11-06 | 0.20 |
| 2025-11-05 | 0.20 |
| 2025-11-04 | 0.19 |
| 2025-11-03 | 0.16 |
| 2025-10-31 | 0.16 |
| 2025-10-30 | 0.16 |
| 2025-10-29 | 0.15 |
| 2025-10-28 | 0.16 |
| 2025-10-27 | 0.13 |
| 2025-10-24 | 0.14 |
| 2025-10-23 | 0.16 |
| 2025-10-22 | 0.16 |
| 2025-10-21 | 0.16 |
| 2025-10-20 | 0.15 |
| 2025-10-17 | 0.16 |
| 2025-10-16 | 0.15 |
| 2025-10-15 | 0.14 |
| 2025-10-14 | 0.15 |
| 2025-10-13 | 0.15 |
| 2025-10-10 | 0.15 |
| 2025-10-09 | 0.15 |
| 2025-10-08 | 0.13 |